Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity

Autor: Hamza Abrar Mughal, Mette T Mouritzen, Zsuzsanna Takacs-Szabó, Weronika Maria Szejniuk

Publikováno v: Mughal, H A, Mouritzen, M T, Takacs-Szabó, Z & Szejniuk, W M 2022, ' Treatment of induced oligometastatic disease after partial response to immunochemotherapy in patient with stage IV non-small cell lung cancer and severe toxicity ', BMJ Case Reports, vol. 15, no. 12, e252590 . https://doi.org/10.1136/bcr-2022-252590

Treatment of induced oligometastatic disease after partial response to systemic antineoplastic therapy in non-small cell lung cancer (NSCLC) remains controversial. The introduction of immune checkpoint inhibitors (ICIs) has revolutionised the treatme

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::468f514d10dc7174442b3f85928cfb45
https://vbn.aau.dk/da/publications/56fb0225-5d58-4fd2-81b5-c97a7f44ea31